Overview
Intramural NIAID Research Opportunities (INRO) promotes biomedical research training in allergic, immunologic, and infectious diseases. Applicants for INRO should be talented senior-level undergraduate students, those who have recently completed a master’s degree, or those who are in their final year of a master’s degree program. Through INRO, the Office of Research Training & Development (ORTD) at the National Institutes of Health, National Institute of Allergy and Infectious Diseases sponsors postbaccalaureate research trainees (postbacs) from U.S. populations underrepresented in the biomedical sciences and those dedicated to promoting diversity and inclusion — as defined by Notice of NIH’s Interest in Diversity. Individuals from underrepresented populations and/or disadvantaged backgrounds are strongly encouraged to apply.
Candidates must demonstrate a strong commitment to the promotion of diversity and inclusion in the biomedical sciences and be actively pursuing a postbac research training position – also called an Intramural Research Training Award (IRTA) – in NIAID at the time of their INRO application.
If selected for INRO, finalists will have the opportunity to get to know the other finalists in their cohort and meet with prospective NIAID mentors, with the expectation that all finalists will join an NIAID laboratory and start their paid postbac training on June 9, 2025.
NIH Postbac IRTA positions are full-time research training positions for 1 – 2 years.
Applications will be accepted from September 1 through December 1, 2024. Applicants must apply for the NIH Postbac IRTA Program and submit an INRO supplementary questionnaire.
For more details, join us for an upcoming virtual information session:
Wednesday, September 18 @ 7 PM (ET)
About National Institute of Allergy and Infectious Diseases
NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world.
In fiscal year 2021, the NIAID budget was $6.1 billion. The Institute dedicated these funds to support scientific opportunities that align with its mission and address domestic and global health problems and diseases.
Among the 27 Institutes and Centers that comprise the National Institutes of Health, NIAID has a unique mandate, which requires the Institute to respond to emerging public health threats. Toward this end, NIAID manages a complex and diverse research portfolio that aims to do the following:
Expand the breadth and depth of knowledge in all areas of infectious, immunologic, and allergic diseases
Develop flexible domestic and international research capacities to respond appropriately to emerging and re-emerging disease threats at home and abroad
NIAID advances the understanding, diagnosis, and treatment of many of the world’s most intractable and widespread diseases. Key research areas include newly emerging and re-emerging infectious diseases such as tuberculosis and influenza, HIV/AIDS, biodefense, and immune-mediated diseases including asthma and allergy.
